Your browser doesn't support javascript.
loading
Clinical effectiveness of a multitarget urine DNA test for urothelial carcinoma detection: a double-blinded, multicenter, prospective trial.
Wu, Junlong; Lin, Yuda; Yang, Kaiwei; Liu, Xiao; Wang, Huina; Yu, Tingting; Tao, Ran; Guo, Jing; Chen, Libin; Cheng, Huanqing; Lou, Feng; Cao, Shanbo; Yu, Wei; Hu, Hailong; Ye, Dingwei.
Afiliação
  • Wu J; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, 200032, People's Republic of China.
  • Lin Y; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Yang K; Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, 23 Pingjiang Road, Hexi District, Tianjin, 300211, People's Republic of China.
  • Liu X; Tianjin Key Laboratory of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
  • Wang H; Department of Urology, Peking University First Hospital, No. 8 Xishiku Dajie, Xicheng District, Beijing, 100034, People's Republic of China.
  • Yu T; Acornmed Biotechnology Co., Ltd, Beijing, 100176, People's Republic of China.
  • Tao R; Acornmed Biotechnology Co., Ltd, Beijing, 100176, People's Republic of China.
  • Guo J; Acornmed Biotechnology Co., Ltd, Beijing, 100176, People's Republic of China.
  • Chen L; Acornmed Biotechnology Co., Ltd, Beijing, 100176, People's Republic of China.
  • Cheng H; Acornmed Biotechnology Co., Ltd, Beijing, 100176, People's Republic of China.
  • Lou F; Acornmed Biotechnology Co., Ltd, Beijing, 100176, People's Republic of China.
  • Cao S; Acornmed Biotechnology Co., Ltd, Beijing, 100176, People's Republic of China.
  • Yu W; Acornmed Biotechnology Co., Ltd, Beijing, 100176, People's Republic of China. fenglou@acornmed.com.
  • Hu H; Acornmed Biotechnology Co., Ltd, Beijing, 100176, People's Republic of China. shanbocao@acornmed.com.
  • Ye D; Department of Urology, Peking University First Hospital, No. 8 Xishiku Dajie, Xicheng District, Beijing, 100034, People's Republic of China. yuweif@126.com.
Mol Cancer ; 23(1): 57, 2024 03 19.
Article em En | MEDLINE | ID: mdl-38504268
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Limite: Humans Idioma: En Revista: Mol Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Limite: Humans Idioma: En Revista: Mol Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article